Bnp Paribas Arbitrage, Snc »

Crescent Biopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $48 4 12.00
2025-06-30 $65 4 16.25

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Crescent Biopharma

FMR
Fairmount Funds Management
VR Adviser
BVF
Tang Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Driehaus Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Crescent Biopharma